Skip to content
OpenCapital
Get started

Research Solutions RSSS Stock-based compensation expense — restricted shares

Other financials

Income statement

See full
Revenue$12.1M-4.3%
Gross profit$6.3M0.0%
Operating income$1.0M+87.6%
Net income$860.2K+297%
EPS (diluted)$0.03+200%

Balance sheet

See full
Cash & equivalents$12.1M+22.3%
Total equity$19.1M+69.7%
Total assets$45.9M+1.6%

Cash flow

See full
Operating cash flow$1.0M-65.2%
CapEx$4.0K-34.4%
Free cash flow$1.0M-65.2%

Valuation

See full
Market cap$77.6M-16.2%
P/E17.2×-56.0×
P/S1.6×-0.3×

Profitability

See full
Gross margin51.4%+3.2pp
Operating margin8.1%—
Net margin9.3%+6.3pp
FCF margin11.8%—

Returns & leverage

See full
Return on equity29.8%+19.8pp
Debt / equity0×—
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Research Solutions in its filing.

Tagged under the XBRL concept us-gaap:RestrictedStockExpense.

The official record: Research Solutions’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Research Solutions's stock-based compensation expense — restricted shares.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Research Solutions's stock-based compensation expense — restricted shares?
Research Solutions (RSSS) reported stock-based compensation expense — restricted shares of $158.05K in Q1 2026.
How has Research Solutions's stock-based compensation expense — restricted shares changed year-over-year?
Research Solutions's stock-based compensation expense — restricted shares decreased by 70.5% year-over-year, from $535.93K to $158.05K.
What is the long-term trend for Research Solutions's stock-based compensation expense — restricted shares?
Over 3 years (2022 to 2025), Research Solutions's stock-based compensation expense — restricted shares has grown at a 39.6% compound annual growth rate (CAGR), from $557.5K to $1.52M.